This week, Marianna sits down with Carolyn Chu and Astha Kanani from the National Clinician Consultation Center (NCCC) to talk about treatment interruptions when it comes to HIV and Hepatitis C or HCV. Learn about why this can happen, the impact on treatment outcomes, and what you as an HIV care provider can do to prevent them. 

-- 

Reach out to the NCCC at 844-ASK-NCCC or 844-275-6222. 

Learn more at nccc.ucsf.edu. 

Resources mentioned in this episode: 

Dannenberg C, Matthews H, Hüfner A, et al.  Long-term real-world use of cabotegravir/rilpivirine: adherence and virological efficacy over a 44-month observation period.  Infect Dis Ther.  2025:14 (8):1775-1797.

De La Hoz A, Pooja A, Kancharla A, et al.  Characteristics and outcomes of direct-acting antiviral experienced patients with hepatitis C undergoing retreatment at an essential hospital in the United States.  Open Forum Infect Dis.  2024;11(12):ofae704.

-- 

Help us track the number of listeners our episode gets by filling out this brief form! (https://www.e2NECA.org/?r=AQX7941)

--
Want to chat? Email us at podcast@necaaetc.org with comments or ideas for new episodes.

--
Check out our free online courses: www.necaaetc.org/rise-courses

--
Download our HIV mobile apps:

Google Play Store: https://play.google.com/store/apps/developer?id=John+Faragon&hl=en_US&gl=US

Apple App Store: https://apps.apple.com/us/developer/virologyed-consultants-llc/id1216837691